Home » Topics » BioWorld Science

BioWorld Science
RSS

Amiprilose advances to phase III in rheumatoid arthritis

April 12, 1996

COX-2 inhibitor research continues at Merck Frosst

April 12, 1996

Virulizin clinical trials reinitiated for KS

April 12, 1996

Cell Genesys to evaluate new gene therapy for AIDS

April 12, 1996

DaunoXome approved as first-line treatment for KS

April 12, 1996

Expanded access for delavirdine initiated

April 12, 1996

New patent issued to Interferon Sciences

April 12, 1996

Anti-HSV compound karalicin

April 12, 1996

Dutch approval for Amphocil

April 12, 1996

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...